Poorer nations still lack access to world’s key antibiotics

"The world’s biggest drugs makers have pressed on in the fight against superbugs despite the pandemic, but millions of people in poorer countries, where the risk of drug-resistant infections is highest, are still missing out on key antibiotics," writes Julia Kollewe in The Guardian.

The article explores the latest research from the Access to Medicine Foundation, focusing on the 2021 Antimicrobial Resistance Benchmark's findings about access to crucial antibacterials and antifungals.

Click here to read the full article in The Guardian.